US Patent 8822417 Albumin variants

Patent 8822417 was granted and assigned to Novozymes on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88224170

Patent Inventor Names

Karen Delahay0

Andrew Plumridge0

Bjorn Dalhus0

Esben Peter Friis0

Inger Sandlie0

Jan Terje Andersen0

Jason Cameron0

Date of Patent

September 2, 2014

Patent Application Number

134639440

Date Filed

May 4, 2012

Patent Citations Received

‌

US Patent 12116400 Albumin variants and conjugates

‌

US Patent 12016881 Methods and reagents for modulating macrophage phenotype

Patent Primary Examiner

‌

Julie Ha

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8822417 Albumin variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API